Nasopharyngeal Carcinoma (NPC)
			Bmi-1
plays an important role in the development 
				and progression of nasopharyngeal carcinoma, and that Bmi-1 is a 
				valuable marker for assessing the prognosis of nasopharyngeal 
				carcinoma patients.
				
				PMID: 16778197
CENP-H protein
a valuable marker of NPC progression. High 
				CENP-H expression is associated with poor overall survival in 
				NPC patients.
				
				PMID: 17255272
			CYFRA 21-1
a new tumor marker in nasopharyngeal carcinoma. 
				PMID: 9604997
			Cytokeratin 19 (CK-19
the presence of 
			CK-19 mRNA in the peripheral blood may be a potential marker of 
			micrometastasis for nasopharyngeal carcinoma (NPC).
				PMID: 11802221
EBERs
can be used as a sensitive marker to identify nasopharyngeal carcinoma (NPC) cells at various metastatic sites by techniques of in situ hybridization, and that demonstration of EBERs in lesions of undifferentiated histology may be useful as a diagnostic adjunct for NPC presenting as metastatic cancer of unknown origin. PMID: 8646721
			EBV DNA
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. 
				PMID: 12450734
EBV-specific DNase
may be a useful marker for detection of 
				patients with NPC, and they imply that individuals having high 
				levels of antibody to EBV DNase activity may have an increased 
				risk of development of NPC.
				
				PMID: 2542436
				
				Epstein-Barr virus-specific DNase is a marker for the early 
				detection of nasopharyngeal carcinoma. 
				
				PMID: 2995572
IgA/VCA
is of marginal significance in the monitoring 
				of nasopharyngeal 
				carcinoma (NPC) patients during 
				follow-up.
				
				PMID: 7926060
MB-1
may be useful as a tumor marker of
				nasopharyngeal 
				carcinoma (NPC).
				
				PMID: 7510513
TK (thymidine kinase)
the TK ELISA presents a strong predictor of 
				NPC and, in its refined form, has improved pickup rates.
				
				PMID: 11267982
			TPS (Tissue 
			polypeptide specific antigen)
may have a 
			potential clinical role as a valuable tumor marker for 
			nasopharyngeal carcinoma (NPC).
				PMID: 11205197
serum/plasma EBV 
			DNA constitutes a reliable tumor marker prior to, during, and after 
			treatment of NPC.
				PMID: 10741733
VCA IgA
specific VCA IgA antibody may serve as a 
				better marker for screening nasopharyngeal carcinoma (NPC) than 
				EBV DNA detected by PCR.
				
				PMID: 11316043